Huntington’s disease researcher wins international award
Professor Sarah Tabrizi, director of the Huntington’s Disease Centre at University College London’s (UCL) Institute of Neurology, has received the 2017 International Leslie Gehry Brenner prize for Innovation in Science.
The $100,000 prize was awarded by the Hereditary Disease Foundation on November 6 in New York in recognition of “her outstanding contributions to innovative clinical trials and to clinical care for people with Huntington's disease and their families.” The award committee commended Professor Tabrizi for her work advancing understanding of Huntington’s and developing new therapies for the disease.
The Huntington’s Disease Association is delighted to congratulate Professor Tabrizi on this much deserved award. Professor Tabrizi's work in Huntington's disease research has had ground breaking results that has moved the disease a step closer towards an effective treatment.
Cath Stanley, Chief Executive, said:
"Professor Tabrizi has dedicated her working life to the field of Huntington's disease research. This reward is a fitting tribute to her dedication and work".
Professor Tabrizi leads a team at the UCL Huntington’s Disease Centre that is conducting a trial of a new ‘gene silencing’ treatment. It’s the world’s first trial in patients to slow, stop, prevent or reverse Huntington’s, using a method that targets the root cause of the disease – a gene producing a protein called huntingtin.
Photo: UCL
Professor Sarah Tabrizi, director of the Huntington’s Disease Centre at University College London’s (UCL) Institute of Neurology, has received the 2017 International Leslie Gehry Brenner prize for Innovation in Science.
The $100,000 prize was awarded by the Hereditary Disease Foundation on November 6 in New York in recognition of “her outstanding contributions to innovative clinical trials and to clinical care for people with Huntington's disease and their families.” The award committee commended Professor Tabrizi for her work advancing understanding of Huntington’s and developing new therapies for the disease.
The Huntington’s Disease Association is delighted to congratulate Professor Tabrizi on this much deserved award. Professor Tabrizi's work in Huntington's disease research has had ground breaking results that has moved the disease a step closer towards an effective treatment.
Cath Stanley, Chief Executive, said:
"Professor Tabrizi has dedicated her working life to the field of Huntington's disease research. This reward is a fitting tribute to her dedication and work".
Professor Tabrizi leads a team at the UCL Huntington’s Disease Centre that is conducting a trial of a new ‘gene silencing’ treatment. It’s the world’s first trial in patients to slow, stop, prevent or reverse Huntington’s, using a method that targets the root cause of the disease – a gene producing a protein called huntingtin.
Photo: UCL